Neuronetics Expands NeuroStar® Advanced Therapy’s Proprietary TrakStar® Platform
MALVERN, Pa., Feb. 23, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced its first of several TrakStar® Patient Data Management System software releases this year. In conjunction, the Company is launching a new educational campaign called “Get There FASTER with TrakStar,” which will encourage current and new NeuroStar providers to unlock all the potential features of TrakStar.
Related news for (STIM)
- Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
- Neuronetics Reports First Quarter 2025 Financial and Operating Results
- Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/04/25 01:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 03/04/25 12:00 PM